Skip to main content
. 2013 Mar 25;63(609):e250–e255. doi: 10.3399/bjgp13X665215

Table 2.

Clinical features of kidney cancer (all ages)

Feature Cases, n (%) n = 3149 Controls, n (%) n = 14091 Likelihood ratioa (95% CI) Odds ratio in multivariable analysis b (95% CI)
Symptoms
  Visible haematuria 558 (18) 97 (1) 26 (21 to 32) 37 (28 to 49)
  Back pain 341 (11) 901 (6) 1.7 (1.5 to 1.9) 1.4 (1.2 to 1.7)
  Abdominal pain 350 (11) 514 (4) 3.1 (2.7 to 3.5) 2.8 (2.4 to 3.4)
  Fatigue 210 (7) 405 (3) 2.3 (2.0 to 2.7) 1.5 (1.2 to 1.9)
  Constipation 194 (6) 420 (3) 2.1 (1.8 to 2.4) 1.4 (1.1 to 1.7)
  Nausea 171 (5) 263 (2) 2.9 (2.4 to 3.5) 1.8 (1.4 to 2.3)

Diseases
  Lower urinary tract infection 339 (11) 608 (4) 2.5 (2.2 to 2.8) 1.8 (1.5 to 2.1)

Investigations
  Raised inflammatory markers 783 (25) 993 (7) 3.5 (3.2 to 3.8) 2.4 (2.1 to 2.8)
  Low haemoglobin 738 (23) 968 (7) 3.4 (3.1 to 3.7) 1.9 (1.6 to 2.2)
  Raised liver function test 654(21) 1526 (11) 1.9 (1.8 to 2.1) 1.3 (1.2 to 1.5)
  Raised creatinine 565 (18) 1095 (8) 2.3 (2.1 to 2.5) 1.7 (1.5 to 2.0)
  Raised blood sugar 485 (15) 1378 (10) 1.6 (1.4 to 1.7) 1.2 (1.1 to 1.4)
  Thrombocytosis 348 (11) 251 (2) 6.2 (5.3 to 7.3) 2.2 (1.7 to 2.7)
  Leukocytosis 304 (10) 330 (2) 4.1 (3.5 to 4.8) 1.5 (1.2 to 1.9)
  Microcytosis 233 (7) 158 (1) 6.6 (5.4 to 8.1) 2.6 (1.9 to 3.4)
a

The univariate likelihood ratio, showing the likelihood of having a specific feature in a patient with kidney cancer, compared with the likelihood of having it in a patient without cancer.

b

In multivariate conditional logistic regression, containing all 15 variables